Meibomian Gland Dysfunction in Type 2 Diabetic Patients

Table 3

Comparison of meibomian gland function and tear film parameters between the symptomatic and asymptomatic patients in the diabetic group.

Parameters	Symptomatic patients	Asymptomatic patients	p
The history of diabetes	12.69 ± 8.32	9.73 ± 5.99	0.305
Fasting blood glucose (mg/dl)	8.71 ± 4.47	9.74 ± 5.89	0.884
OSDI	25.41 ± 13.45	4.01 ± 3.85	<0.001
TBUT (s)	2.71 ± 0.88	4.62 ± 2.60	<0.001
Fluorescein score	1.75 ± 2.24	1.79 ± 2.70	0.745
Schirmer (mm)	5.12 ± 3.47	5.30 ± 3.90	0.932
TMH (mm)	0.18 ± 0.10	0.19 ± 0.10	0.729
NIBUT-1st (s)	6.46 ± 5.34	7.63 ± 5.83	0.311
NIBUT-avg (s)	8.22 ± 6.37	9.86 ± 6.61	0.198
LLT	79.40 ± 22.32	75.16 ± 20.31	0.289
Meibography score	3.90 ± 1.40	4.54 ± 1.26	0.067
Lid margin abnormality score	2.50 ± 0.66	2.44 ± 0.81	0.892
The number of expressible glands
Temporal third	1.42 ± 1.88	1.26 ± 1.58	0.948
Central third	1.00 ± 1.60	1.56 ± 1.50	0.153
Nasal third	0.75 ± 1.36	1.00 ± 1.24	0.271